Cumberland Pharmaceuticals (CPIX) Goodwill & Intangibles (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Goodwill & Intangibles of $13.7 million for Q1 2026, down 23.43% on a YoY basis from $17.9 million in Q1 2025, and down 8.26% sequentially from $14.9 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Goodwill & Intangibles data on file, last reported at $13.7 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 23.43% year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (down 23.43% YoY), and the FY2025 full-year result was $14.9 million, down 20.89% from the prior year.
- Goodwill & Intangibles fell to $13.7 million in Q1 2026, from $14.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $36.4 million in Q1 2022 to a low of $13.7 million in Q1 2026.
- A 5-year average of $24.0 million and a median of $22.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles soared 30.48% in 2022 and fell 27.49% in 2024, its largest moves.
- Tracing CPIX's Goodwill & Intangibles over 5 years: stood at $31.5 million in 2022, then fell by 25.34% to $23.5 million in 2023, then dropped by 19.7% to $18.9 million in 2024, then declined by 20.89% to $14.9 million in 2025, then slipped by 8.26% to $13.7 million in 2026.
- Business Quant data shows CPIX's Goodwill & Intangibles at $13.7 million in Q1 2026, $14.9 million in Q4 2025, and $15.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.71 Mn |
| Dec 31, 2025 | 14.94 Mn |
| Sep 30, 2025 | 15.92 Mn |
| Jun 30, 2025 | 16.90 Mn |
| Mar 31, 2025 | 17.90 Mn |
| Dec 31, 2024 | 18.89 Mn |
| Sep 30, 2024 | 20.33 Mn |
| Jun 30, 2024 | 21.37 Mn |
| Mar 31, 2024 | 22.44 Mn |
| Dec 31, 2023 | 23.52 Mn |
| Sep 30, 2023 | 28.04 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 30.30 Mn |
| Dec 31, 2022 | 31.50 Mn |
| Sep 30, 2022 | 30.98 Mn |
| Jun 30, 2022 | 34.91 Mn |
| Mar 31, 2022 | 36.41 Mn |
| Dec 31, 2021 | 24.84 Mn |
| Sep 30, 2021 | 25.80 Mn |
| Jun 30, 2021 | 26.77 Mn |